A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera
Clinical trial NCT03287245 · TERMINATED
Trial details
- NCT number
- NCT03287245
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2020-03-03
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.